Literature DB >> 8835355

Characteristics of IL-6 and TNF-alpha production by respiratory syncytial virus-infected macrophages in the neonate.

K Matsuda1, H Tsutsumi, S Sone, Y Yoto, K Oya, Y Okamoto, P L Ogra, S Chiba.   

Abstract

The production of IL-6 and TNF-alpha and the expression of their mRNA were studied with neonatal (cord blood) and adult blood monocyte-derived macrophages (MDM) after in vitro infection with respiratory syncytial virus (RSV). Cord blood MDM exhibited production of high levels of IL-6 within 24 hr after infection. Little or no IL-6 production was detected after 24-48 hr and after in vitro stimulation with inactivated (nonreplicating) virus. Adult blood MDM also produced high levels of IL-6 within 24 hr of RSV infection. Unlike cord blood MDM, adult MDM demonstrated significant activity of IL-6 after 24 hr of infection with live RSV and after exposure to the inactivated virus. The pattern of TNF-alpha production by cord and adult blood MDM after live RSV infection resembled closely the pattern of IL-6 production. Both cell types produced TNF-alpha in the first 24 hr after infection. However, little or no production was observed after 24 hr of infection and after exposure to the inactivated virus. The profile of mRNA expression was similar to the production of IL-6 or TNF-alpha. mRNA expression occurred over a shorter period in cord blood MDM. These observations suggest that inflammatory and immunoregulatory cytokines, such as IL-6 and TNF-alpha, are produced by neonatal as well as previously primed adult macrophages. However, neonatal cells may be less efficient in inducing IL-6 production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835355     DOI: 10.1002/(SICI)1096-9071(199602)48:2<199::AID-JMV13>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

Review 1.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

2.  Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1beta-converting enzyme gene expression but does not cause apoptosis.

Authors:  R Takeuchi; H Tsutsumi; M Osaki; K Haseyama; N Mizue; S Chiba
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection.

Authors:  Peter Rigaux; Kristin E Killoran; Zhijun Qiu; Helene F Rosenberg
Journal:  Virology       Date:  2011-11-30       Impact factor: 3.616

4.  Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation.

Authors:  Sasha J Fach; Alicia Olivier; Jack M Gallup; Theresa E Waters; Mark R Ackermann; Howard D Lehmkuhl; Randy E Sacco
Journal:  Vet Immunol Immunopathol       Date:  2010-02-13       Impact factor: 2.046

5.  Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.

Authors:  Hye Suk Hwang; Ki-Hye Kim; Youri Lee; Young-Tae Lee; Eun-Ju Ko; SooJin Park; Jong Seok Lee; Byung-Cheol Lee; Young-Man Kwon; Martin L Moore; Sang-Moo Kang
Journal:  Hum Vaccin Immunother       Date:  2017-01-27       Impact factor: 3.452

6.  Respiratory syncytial virus infection of neonatal monocytes stimulates synthesis of interferon regulatory factor 1 and interleukin-1beta (IL-1beta)-converting enzyme and secretion of IL-1beta.

Authors:  R Takeuchi; H Tsutsumi; M Osaki; S Sone; S Imai; S Chiba
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow.

Authors:  Kimberly D Dyer; Jennifer M Moser; Meggan Czapiga; Steven J Siegel; Caroline M Percopo; Helene F Rosenberg
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

Authors:  Matthew R Murawski; Glennice N Bowen; Anna M Cerny; Larry J Anderson; Lia M Haynes; Ralph A Tripp; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

9.  The apoptosis of neutrophils is accelerated in respiratory syncytial virus (RSV)-induced bronchiolitis.

Authors:  S Z Wang; P K Smith; M Lovejoy; J J Bowden; J H Alpers; K D Forsyth
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 10.  Respiratory syncytial virus: the virus, the disease and the immune response.

Authors:  Pearay L Ogra
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.